Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone (2009)
- Authors:
- Hirata, Mario Hiroyuki
- Marques, Milano Felipe dos Santos Ferreira
- Himelfarb, Silvia Tchernin
- Silva, F. A.
- Monaco, Maria Isabel del - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Sampaio, M. P. - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Dinkhuysen, J. F. - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Bertolami, Marcelo Chiara - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Armaganijan, Dikran - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Silva, Valéria Ferreira da - Instituto Dante Pazzanese de Cardiologia (IDPC)
- Rodrigues, Alice Cristina
- Hirata, Rosario Dominguez Crespo
- USP affiliated authors: HIRATA, MARIO HIROYUKI - FCF ; HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF
- Unidade: FCF
- Subjects: DIABETES MELLITUS; POLIMORFISMO
- Language: Inglês
- Imprenta:
- Publisher: American Association for Clinical Chemistry
- Publisher place: Washington
- Date published: 2009
- Source:
- Título do periódico: Clinical Chemistry
- ISSN: 1530-8561
- Volume/Número/Paginação/Ano: v. 55, n. 6 suppl., p. A222-A223 res. E-39, 2009
- Conference titles: Annual Meeting of the American Association for Clinical Chemistry
-
ABNT
HIRATA, Mario Hiroyuki et al. Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone. Clinical Chemistry. Washington: American Association for Clinical Chemistry. . Acesso em: 24 abr. 2024. , 2009 -
APA
Hirata, M. H., Marques, M. F. dos S. F., Himelfarb, S. T., Silva, F. A., Monaco, M. I. del, Sampaio, M. P., et al. (2009). Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone. Clinical Chemistry. Washington: American Association for Clinical Chemistry. -
NLM
Hirata MH, Marques MF dos SF, Himelfarb ST, Silva FA, Monaco MI del, Sampaio MP, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rodrigues AC, Hirata RDC. Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone. Clinical Chemistry. 2009 ; 55( 6 suppl.): A222-A223 res. E-39.[citado 2024 abr. 24 ] -
Vancouver
Hirata MH, Marques MF dos SF, Himelfarb ST, Silva FA, Monaco MI del, Sampaio MP, Dinkhuysen JF, Bertolami MC, Armaganijan D, Silva VF da, Rodrigues AC, Hirata RDC. Expression of PPAR'lambda', PPAR'lambda'2, SUR1 and KIR6.2 mRNAin peripheral blood cell in DM 2 patients treated with pioglitazone. Clinical Chemistry. 2009 ; 55( 6 suppl.): A222-A223 res. E-39.[citado 2024 abr. 24 ] - Could SNPs predict Cisplatin toxicity?
- Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis
- Bases farmacogenômicas da resistência medicamentosa
- Inclusion body formation in escherichia coli: a procedure for optimizing production of soluble protein in application to human interferon alpha receptor
- Expression of three polypeptide kfragments of human interferon alpha receptor cloning flexibility and optimization of expression efficienty
- Reconhecimento do receptor recombinante de ifn 'ALFA' / 'BETA' humano por anticorpos policlonais de coelho
- Human interferon alpha receptor: identification of the regeion involved in binding to interferon alpha b
- Cloning and expression of treponema pallidium 47 kda antigen in e. Coli dh5 'ALPHA'
- Estratégia de extração de DNA de manchas sanguíneas para testes forensicos por PCR
- Cloning of a fragment of the 5 noncoding region of HCV genome for using as an internal control in PCR
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas